首页> 外文期刊>Journal of Cancer >The Novel Prognostic Score Combining Red Blood Cell Distribution Width and Body Mass Index (COR-BMI) Has Prognostic Impact for Survival Outcomes in Nasopharyngeal Carcinoma
【24h】

The Novel Prognostic Score Combining Red Blood Cell Distribution Width and Body Mass Index (COR-BMI) Has Prognostic Impact for Survival Outcomes in Nasopharyngeal Carcinoma

机译:结合红细胞分布宽度和体重指数(Cor-BMI)的新型预后评分对鼻咽癌的生存结果具有预后影响

获取原文
           

摘要

Background : A novel inflammation-and nutrition-based scoring system based on red blood cell distribution width and body mass index (COR-BMI) has prognostic value in nasopharyngeal carcinoma (NPC). Here, we assessed the prognostic value of COR-BMI in NPC. Methods : Retrospective study of 2,318 patients with non-metastatic NPC treated at Sun Yat-sen University Cancer Center was conducted. Patients were stratified into three groups using the COR-BMI score, which is based on two objective and easily measurable parameters: red blood cell distribution width (RDW) and body mass index (BMI). Kaplan-Meier survival analyses were used to compare groups; multivariate Cox proportional models were used to calculate overall survival (OS) and disease-free survival (DFS). Results : Four-year overall survival (OS) rates were 88.7%, 84.5%, and 71.4% for patients with COR-BMI scores of 0, 1, and 2 respectively ( P = 0.006). Multivariate Cox proportional hazard analysis revealed COR-BMI was an independent predictor of OS (HR for COR-BMI 1: 1.239, 95% CI: 1.012-1.590; HR for COR-BMI 2: 2.367, 95% CI: 1.311-4.274, P = 0.013), but not DFS ( P = 0.482). In subgroup analysis of metastatic NPC, OS rates decreased as COR-BMI increased. In patients with a COR-BMI score of 1, radiotherapy plus chemotherapy led to better OS than radiotherapy alone. Conclusions : COR-BMI may serve as an indicator of poor prognosis in both NPC and metastatic NPC. Radiotherapy plus chemotherapy may benefit patients with a COR-BMI score of 1.
机译:背景技术:基于红细胞分布宽度和体重指数(Cor-BMI)的新型炎症和基于营养的评分系统具有鼻咽癌(NPC)的预后值。在这里,我们评估了NPC中Cor-BMI的预后价值。方法:对孙中山大学癌症中心治疗2,318例非转移性NPC患者的回顾性研究。使用Cor-BMI评分分层分为三组,基于两个目标且易于测量的参数:红细胞分布宽度(RDW)和体重指数(BMI)。 Kaplan-Meier生存分析用于比较群体;多元COX比例模型用于计算整体存活(OS)和无病生存(DFS)。结果:分别为0,1,2和2的患者,四年的整体生存(OS)率为88.7%,84.5%和71.4%(P = 0.006)。多变量Cox比例危害分析显示Cor-BMI是OS的独立预测因子(Cor-BMI的HR 1:1.239,95%CI:1.012-1.590; HR for Cor-BMI 2:2.367,95%CI:1.311-4.274, P = 0.013),但不是DFS(P = 0.482)。在转移性NPC的亚组分析中,由于Cor-BMI增加,OS率降低。在患者中,Cor-BMI评分为1,放疗加上化疗LED对单独放射疗法的优于优选。结论:Cor-BMI可以作为NPC和转移性NPC预后不良的指标。放射疗法加上化疗可能会使Cor-BMI评分的患者有益于1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号